Cardiovascular Health, Sleep Apnea, and More Retatrutide is also being evaluated in the TRIUMP Trial Program for potential benefits in cardiovascular health, obstructive sleep apnea, fatty liver disease, chronic kidney disease, and even pain associated with osteoarthritis
This beneficial effect appears to be primarily indirect, resulting from weight loss and improved metabolic parameters rather than direct hepatic action
While alpha diversity measures did not significantly differ between groups, beta diversity principal coordinates analyses suggested that mice from the same treatment group were the most similar
Cancer survival and incidence from the surveillance, epidemiology, and end results (SEER) program
Some abnormal plasma elevations of hemostatic parameters, including factor VIII (Freyburger et al, 1997), von Willebrand factor (van den Berg et al, 1995), fibrinogen (von Eckardstein et al, 1994), thrombomodulin (van den Berg et al, 1995), thrombin/antithrombin III complex and activated protein C (Cattaneo, 1999